Abstract
Pharmacological preparations of cannabinoid compounds have a variety of therapeutic uses in medicine, including different pain syndromes, but have not been previously reported as beneficial for cluster headache. We present a patient with cluster headache who was refractory to multiple acute and preventive medications but successfully aborted his attacks with recreational marijuana use; subsequent use of dronabinol provided equally effective pain relief. The beneficial effect may be related to the high concentration of cannabinoid receptors in the hypothalamus, which has been implicated as a site of dysfunction in neuroimaging studies of patients with cluster headache.
MeSH terms
-
Analgesics, Non-Narcotic / administration & dosage*
-
Cannabis / chemistry*
-
Cluster Headache / drug therapy*
-
Cluster Headache / metabolism
-
Cluster Headache / physiopathology
-
Dihydroergotamine / therapeutic use
-
Diphenhydramine / therapeutic use
-
Dronabinol / administration & dosage*
-
Drug Resistance / physiology
-
Drug Therapy, Combination
-
Fructose / analogs & derivatives
-
Fructose / therapeutic use
-
Humans
-
Male
-
Melatonin / therapeutic use
-
Metoclopramide / therapeutic use
-
Topiramate
-
Treatment Outcome
-
Valproic Acid / therapeutic use
-
Young Adult
Substances
-
Analgesics, Non-Narcotic
-
Topiramate
-
Fructose
-
Dihydroergotamine
-
Valproic Acid
-
Dronabinol
-
Diphenhydramine
-
Melatonin
-
Metoclopramide